Companies this past month announced many new products and services that use artificial intelligence to automate complex ...

The company expects to share safety and efficacy results from the RAMP-205 expansion cohort in first-line advanced pancreatic cancer and initial results from the Phase I/IIa trial evaluating VS-7375 ...

Aurinia's Q3 2025 saw 27% LUPKYNIS sales growth and raised 2025 guidance. Discover key earnings insights, clinical updates, and pipeline progress.

BOSTON — Health care professionals should use a broad range of tools to diagnose diabetic peripheral neuropathy, and ...

A new consensus statement by American Association of Clinical Endocrinology emphasizes lifestyle interventions and ...

In my conversations with ASC leaders this year, one theme has been impossible to miss: Change is everywhere. Centers are expanding, merging, modernizing, and rethinking how they use technology to ...

As health systems face financial pressures and tighter budgets, they are also operating in a business environment where ...

Artificial intelligence (AI) is transforming healthcare and life sciences, offering the potential to accelerate drug discovery, enhance diagnostics, and improve patient outcomes. Recent industry ...

The Duke-NUS Graduate Certificate in Health Services Innovation equips healthcare professionals with the tools to drive ...

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced financial results for the third quarter ended September 30, 2025.

CareView Communications, Inc. ("CareView" or the "Company") ("OTCQB: CRVW") is pleased to announce the recent contract awards received by its Service-Disabled Veteran Owned Small Business Partner ...

Technology is an enabler of a clinical model based on local need and guided by national and locally agreed pathways of care. It is essential to start by considering the clinical and business ...